Posted by H. Sandra Chevalier-Batik
Do not use or buy Mommy’s Bliss Nipple Cream
The Food and Drug Administration (FDA) is warning people not to use or buy Mommy’s Bliss Nipple Cream because the product contains potentially harmful ingredients that may cause respiratory problems or vomiting and diarrhea in infants.
Marketed by MOM Enterprises Inc. in San Rafael, Calif., the product […]
Posted by H. Sandra Chevalier-Batik
FDA News
FOR IMMEDIATE RELEASE
May 23, 2008
Media Inquiries:
Rita Chappelle, 301-827-6242
Consumer Inquiries:
888-INFO-FDA
FDA Warns Consumers Against Using Mommy’s Bliss Nipple Cream
Product can be harmful to nursing infants
The U.S. Food and Drug Administration is warning consumers not to use or purchase Mommy’s […]
Posted by H. Sandra Chevalier-Batik
New Efforts to Help Improve Medical Products for Patient Safety and Quality of Medical Care
HHS Secretary Mike Leavitt today announced efforts underway at the U.S. Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS) that will complement each other to improve patient safety and the quality of medical care.
“This initiative […]
Posted by H. Sandra Chevalier-Batik
FDA News
FOR IMMEDIATE RELEASE
May 16, 2008
Media Inquiries:
Rita Chappelle, 301-827-6242
Consumer Inquiries:
888-INFO-FDA
FDA Obtains Permanent Injunction Against Scientific Laboratories, Inc.
Company manufactures and distributes unapproved and adulterated drugs
The U.S. Food and Drug Administration (FDA) today announced that Scientific Laboratories Inc., and its president, Rajeshwari Patel, and […]
Posted by H. Sandra Chevalier-Batik
New Data on Thromboembolic Events with Ortho Evra Contraceptive Patch
The prescribing information for the Ortho Evra Contraceptive Transdermal Patch is being updated with results of a new study on the risk of venous thromboembolism. This study found that women aged 15-44 who used the birth control patch were at higher risk of developing venous thromboembolism […]
Posted by H. Sandra Chevalier-Batik
What are fentanyl skin patches?
FENTANYL (Duragesic®, E-TRANS® Fentanyl) relieves moderate to severe chronic pain. Fentanyl patches are commonly used to treat pain associated with cancer. Once the patch is applied, the medicine is slowly absorbed through your skin into the bloodstream to help control your pain. Generic fentanyl skin patches are available.
FDA Recalls and Safety […]
Posted by H. Sandra Chevalier-Batik
FDA Notifies Public of Adverse Reactions Linked to Botox Use
Ongoing safety review of Botox, Botox Cosmetic and Myobloc taking place
The U.S. Food and Drug Administration today notified the public that Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) have been linked in some cases to adverse reactions, including respiratory […]
March 28, 2008 – 12:19 pm
Posted by H. Sandra Chevalier-Batik
FDA News
FOR IMMEDIATE RELEASE
March 27, 2008
Media Inquiries:
Chris DiFrancesco, 301-827-6242
Consumer Inquiries:
888-INFO-FDA
FDA Identifies First Steps in Requirements for Safety Plans for Certain Drugs and Biologics
New FDAAA requirements being implemented
The U.S. Food and Drug Administration has identified 25 drugs and biologic products that will be required […]
February 14, 2008 – 1:19 pm
Posted by H. Sandra Chevalier-Batik
Sherwood Brands Announces Nationwide Recall of
Pokémon Branded “Valentine Cards and Pops” —Because They May Contain Metal Fragments
FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.
FOR IMMEDIATE RELEASE […]
January 26, 2008 – 12:22 pm
Posted by H. Sandra Chevalier-Batik
After decades of inattention to the possible psychiatric side effects of experimental medicines, the Food and Drug Administration is now requiring drug makers to study closely whether patients become suicidal during clinical trials.
The new rules represent one of the most profound changes of the past 16 years to regulations governing drug development. But […]
Category Archives: 
BlogoSquare